Prognostic Factors and Survival Benefits of Antitumor Treatments for Advanced Non-Small Cell Lung Cancer Patients With Central Nervous System Metastasis With or Without Driver Genes: A Chinese Single-Center Cohort Study

Prognostic Factors and Survival Benefits of Antitumor Treatments for Advanced Non-Small Cell Lung Cancer Patients With Central Nervous System Metastasis With or Without Driver Genes: A Chinese Single-Center Cohort Study

BackgroundThe prognosis of non-small cell lung cancer (NSCLC) patients with central nervous system (CNS) metastasis is poor. The treatment for CNS metastasis could prolong the overall survival of NSCLC patients. We aimed to investigate the prognostic factors of Chinese NSCLC patients with CNS metast...

Full description

Bibliographic Details
Main Authors: Xiaoxing Gao, Minjiang Chen, Xiaoyan Liu, Yuequan Shi, Hongge Liang, Qing Zhou, Jing Zhao, Ruili Pan, Wei Zhong, Yan Xu, Mengzhao Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Oncology
Subjects:
central nervous system metastasis
non-small-cell lung cancer
cohort study
prognostic factors
treatment outcome
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.879554/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.879554/full

Similar Items